Efficacy and safety of leronlimab in patients with non-alcoholic steatohepatitis: topline results of NASH01 clinical trial

Noureddin, M; Lawitz, E; Ritter, A; Hassanein, T; Bowman, K; Kelly, S; Mahyari, E; Sacha, J; Hansen, S; Recknor, C

JOURNAL OF HEPATOLOGY, 2022; 77 (): S713